Next Article in Journal / Special Issue
Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
Previous Article in Journal / Special Issue
Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
Open AccessReview

Pediatric Invasive Aspergillosis

Department of Pediatrics, Division of Infectious Diseases and Global Health, University of California-San Francisco, 550 16th St, 4th Floor, Box 0434, San Francisco, CA 94143, USA
*
Author to whom correspondence should be addressed.
Academic Editor: William J. Steinbach
J. Fungi 2016, 2(2), 19; https://doi.org/10.3390/jof2020019
Received: 30 April 2016 / Revised: 6 June 2016 / Accepted: 8 June 2016 / Published: 13 June 2016
(This article belongs to the Special Issue Aspergillus fumigatus: From Diagnosis to Therapy)
Invasive aspergillosis (IA) is a disease of increasing importance in pediatrics due to growth of the immunocompromised populations at risk and improvements in long-term survival for many of these groups. While general principles of diagnosis and therapy apply similarly across the age spectrum, there are unique considerations for clinicians who care for children and adolescents with IA. This review will highlight important differences in the epidemiology, clinical manifestations, diagnosis, and therapy of pediatric IA. View Full-Text
Keywords: aspergillosis; pediatric; antifungal aspergillosis; pediatric; antifungal
MDPI and ACS Style

Wattier, R.L.; Ramirez-Avila, L. Pediatric Invasive Aspergillosis. J. Fungi 2016, 2, 19.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop